Txmd price target
Web1y Target Est 5.00 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. WebBut SPCE is basically up 100%+ since it got a 100 buy rating and popped just when it dipped to a 88% buy rating. MOTS has a 100% buy rating as well. SPCE had/has 71% short interest makings it the 3rd most shorted after GME and AMC. Increase in price could be due do short squeeze rather than actual company valuation.
Txmd price target
Did you know?
WebExhibit 4.2 . DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934. As of December 31, 2024, the only class of securities of TherapeuticsMD, Inc., a Nevada corporation (the “Company”), registered under Section 12 of the Securities Exchange Act of 1934, as amended, is … WebThe median TXMD price target (a different metric than the average or mean) was $5.0 as of 2024-04-04, the highest TXMD price target in the range was $5.0 while the lowest TXMD price target in the range was $5.0, with a standard deviation of $0.0. Get the latest Zacks research report on TXMD — FREE. 10 ETFs With Most Upside To Analyst Targets
WebApr 4, 2024 · Stock Price Forecast. According to 8 stock analysts, the average 12-month stock price forecast for TXMD stock is $ 5.1 , which predicts an increase of 39.73%. The … WebMar 29, 2024 · The analyst firm set a price target for 5.00 expecting TXMD to rise to within 12 months (a possible 40.25% upside). 4 analyst firms have reported ratings in the last year. Q.
WebApr 14, 2024 · PACCAR (NASDAQ:PCAR – Get Rating) had its target price lifted by equities researchers at Deutsche Bank Aktiengesellschaft from $70.00 to $72.00 in a research note issued to investors on Wednesday, The Fly reports. The firm presently has a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft’s target price points to a potential upside of … WebApr 11, 2024 · A high-level overview of TherapeuticsMD, Inc. (TXMD) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
WebApr 14, 2024 · 19.82. TherapeuticsMD. $69.96 million. 0.54. -$14.23 million. ($1.43) -2.64. Sanofi has higher revenue and earnings than TherapeuticsMD. TherapeuticsMD is trading at a lower price-to-earnings ...
WebApr 13, 2024 · 3.10. $7.14 billion. $2.83. 19.72. Sanofi has higher revenue and earnings than TherapeuticsMD. TherapeuticsMD is trading at a lower price-to-earnings ratio than Sanofi, indicating that it is ... bob glasgow grief support programWeb41.5k shares, -32.6% compared to typical daily volume over the past 6 months. Typical daily volume is 61.56k shares over the past 6 months. Typical: 2.81 pts (80.7%) occurs 25% of the time. Extreme: 3.66 pts (105.2%) occurs 5% of the … bob glasgow grief supportWebMar 4, 2024 · Get The Latest TXMD Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. Skip to main content. S&P 500 . DOW . QQQ 299.68. MarketBeat Week in Review – 2/27 - 3/3. The Safest Option in Trades! (Ad) In Chicago, adapting electric buses to winter’s challenges. bob g. knightWebJul 31, 2024 · Knight receives license to TX-004HR and TX-001HR and agrees to invest $20 million in TherapeuticsMD MONTREAL & BOCA RATON, Fla.--(BUSINESS WIRE)--Jul. 31, 2024-- Knight Therapeutics Inc. (TSX: GUD) (“Knight”),a Canadian specialty pharmaceutical company, and TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare … bob glascockWebTXMD Growth Metrics. The 4 year net cashflow from operations growth rate now stands at -137.17%. Its 2 year price growth rate is now at -95.09%. Its 3 year price growth rate is now at -98.3%. Over the past 15 months, TXMD's revenue has gone up $2,701,410. The table below shows TXMD's growth in key financial areas (numbers in millions of US ... clip art free new year\u0027s eveWebFeb 5, 2024 · TXMD stock has also been actively discussed among Reddit stocks with current short interest of 24.53%. According to the Reddit community, the stock ranks 41st among the most-shorted stocks . bob glass backgammonWebNumber of Analysts. 3. Standard Deviation. 1.154. Look at TherapeuticsMD's target prices provided by various analysts and compare them. This can help you gain a more balanced … bob glauber twitter